Vazquez JA, Pappas PG, Boffard K, Paruk F, et al. Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris: Results from a Phase 2 Trial. Antimicrob Agents Chemother 2023 Apr 6:e0141922. doi: 10.1128/aac.01419.
PMID: 37022196